28-mer fragment derived from enterocin CRL35 displays an unexpected bactericidal effect on listeria cells

Protein and Peptide Letters

Volumn 22, Issue 6, 2015, Pages 482-488

  Masias, Emilse ^a   Sanches, Paulo R S ^b   Dupuy, Fernando G ^a   Acuña, Leonardo ^a   Bellomio, Augusto ^a   Cilli, Eduardo ^b   Saavedra, Lucila ^c   Minahk, Carlos ^a  

^a UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

Author keywords

Bacteriocins; Enterocin CRL35; Listeria; Synthetic peptides

Indexed keywords

15 MER PEPTIDE; 28 MER PEPTIDE; BACTERIOCIN; ENTEROCIN CRL35; LIPOSOME; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERICIDAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISSOCIATION CONSTANT; ELECTRIC POTENTIAL; LISTERIA; NONHUMAN; PEPTIDE SYNTHESIS; PROTEIN BINDING; PROTEIN STRUCTURE; AMINO ACID SEQUENCE; CHEMISTRY; DRUG EFFECTS; GENETICS; LACTOBACILLACEAE; MEMBRANE POTENTIAL; MICROBIAL VIABILITY; MOLECULAR GENETICS; SYNTHESIS;

LISTERIA;

AMINO ACID SEQUENCE; BACTERIOCINS; LACTOBACILLACEAE; LIPOSOMES; LISTERIA; MEMBRANE POTENTIALS; MICROBIAL VIABILITY; MOLECULAR SEQUENCE DATA;

EID: 84931272338     PISSN: 09298665     EISSN: 18755305     Source Type: Journal    
DOI: 10.2174/0929866522666150506094300     Document Type: Article

References (29)

1. Elsser-Gravesen, D.; Elsser-Gravesen, A. Biopreservatives. Adv. Biochem. Eng. Biotechnol., 2014, 143, 29-49.
2. Cleveland, J.; Montville, T.J.; Nes, I.F.; Chikindas, M.L. Bacteriocins: safe, natural antimicrobials for food preservation. Int. J. Food Microbiol., 2001, 71, 1-20.
3. Benmechernene, Z.; Fernandez-No, I.; Kihal, M.; Bohme, K.; et al. Recent Patents on Bacteriocins: Food and Biomedical Applications. Recent Pat. DNA Gene Seq., 2013, 7, 66-73.
4. Cotter, P.D.; Ross, R.P.; Hill, C. Bacteriocins-a viable alternative to antibiotics? Nat. Rev. Microbiol., 2013, 11, 95-105.
5. Farias, M.E.; De Ruiz Holgado, A.A.P.; Sesma, F. Bacteriocin production by lactic acid bacteria isolated from regional cheeses: Inhibition of foodborne pathogens. J. Food Prot., 1994, 57, 1013-1015.
6. Wachsman, M.B.; Farías, M.E.; Takeda, E.; Sesma, F.; et al. Antiviral activity of enterocin CRL35 against herpesviruses. Int. J. Antimicrob. Agents, 1999, 12, 293-299.
7. Reddy, K.V.R.; Yedery, R.D.; Aranha, C. Antimicrobial peptides: premises and promises. Int. J. Antimicrob. Agents, 2004, 24, 536-547.
8. Minahk, C.J.; Farías, M.E.; Sesma, F.; Morero, R.D. Effect of enterocin CRL35 on Listeria monocytogenes cell membrane. FEMS Microbiol. Lett., 2000, 192, 79-83.
9. Minahk, C.J.; Dupuy, F.; Morero, R.D. Enhancement of antibiotic activity by sub-lethal concentrations of enterocin CRL35. J. Antimicrob. Chemother., 2004, 53, 240-246.
10. Salvucci, E.; Hebert, E.M.; Sesma, F.; Saavedra, L. Combined effect of synthetic enterocin CRL35 with cell wall, membraneacting antibiotics and muranolytic enzymes against Listeria cells. Lett. Appl. Microbiol., 2010, 51, 191-195.
11. Knoetze, H.; Todorov, S.D.; Dicks, L.M.T. A class IIa peptide from Enterococcus mundtii inhibits bacteria associated with otitis media. Int. J. Antimicrob. Agents, 2008, 31, 228-234.
12. Saavedra, L.; Minahk, C.; de Ruiz Holgado, A.P.; Sesma, F. Enhancement of the enterocin CRL35 activity by a synthetic peptide derived from the NH2-terminal sequence. Antimicrob. Agents Chemother., 2004, 48, 2778-2781.
13. Salvucci, E.; Saavedra, L.; Sesma, F. Short peptides derived from the NH2-terminus of subclass IIa bacteriocin enterocin CRL35 show antimicrobial activity. J. Antimicrob. Chemother., 2007, 59, 1102-1108.
14. Bhugaloo-Vial, P.; Douliez, J.P.; Moll, D.; Dousset, X.; et al. Delineation of key amino acid side chains and peptide domains for antimicrobial properties of divercin V41, a pediocin-like bacteriocin secreted by Carnobacterium divergens V41. Appl. Environ. Microbiol., 1999, 65, 2895-2900.
15. Carpino, L.A.; Han, G.Y. 9-Fluorenylmethoxycarbonyl aminoprotecting group. J. Org. Chem., 1972, 37, 3404-3409.
16. Wehr, H.M.; Frank, J.F. Standard methods for the examination of dairy products, 17th ed.; American Public Health Association: Washington, 2004.
17. Hall, M.J.; Middleton, R.F.; Westmacott, D. The fractional inhibitory concentration (FIC) index as a measure of synergy. J. Antimicrob. Chemother, 1983, 11, 427-433.
18. Stein, S.; Böhlen, P.; Udenfriend, S. Studies on the kinetics of reaction and hydrolysis of fluorescamine. Arch. Biochem. Biophys., 1974, 163, 400-403.
19. De Arcuri, B.F.; Vechetti, G.F.; Chehin, R.N.; Goni, F.M.; et al. Protein-induced fusion of phospholipid vesicles of heterogeneous sizes. Biochem. Biophys. Res. Commun., 1999, 262, 586-90.
20. Minahk, C.J.; Saavedra, L.; Sesma, F.; Morero, R. Membrane viscosity is a major modulating factor of the enterocin CRL35 activity. Biochimie, 2005, 87, 181-186.
21. Gradinaru, C.C.; Marushchak, D.O.; Samim, M.; Krull, U.J. Fluorescence anisotropy: from single molecules to live cells. Analyst, 2010, 135, 452-459.
22. Derksen, D.J.; Boudreau, M.A.; Vederas, J.C. Hydrophobic interactions as substitutes for a conserved disulfide linkage in the type IIa bacteriocins, leucocin A and pediocin PA-1. Chembiochem., 2008, 9, 1898-1901.
23. Acuña, L.; Morero, R.D.; Bellomio, A. Development of Wide-Spectrum Hybrid Bacteriocins for Food Biopreservation. Food Bioprocess Technol., 2011, 4, 1029-1049.
24. Ovchinnikov, K.V.; Kristiansen, P.E.; Uzelac, G.; Topisirovic, L.; et al. Defining the structure and receptor binding domain of the leaderless bacteriocin LsbB. J. Biol. Chem., 2014, 289, 23838-23845.
25. Bodapati, K.C.; Soudy, R.; Etayash, H.; Stiles, M.; et al. Design, synthesis and evaluation of antimicrobial activity of N-terminal modified Leucocin A analogues. Bioorg. Med. Chem., 2013, 21, 3715-3722.
26. Nissen-Meyer, J.; Nes, I.F. Ribosomally synthesized antimicrobial peptides: their function, structure, biogenesis, and mechanism of action. Arch. Microbiol., 1997, 167, 67-77.
27. Xu, W.; Zhu, X.; Tan, T.; Li, W.; et al. Design of embeddedhybrid antimicrobial peptides with enhanced cell selectivity and anti-biofilm activity. PloS One, 2014, 9, e98935.
28. Mkrtchyan, H.; Gibbons, S.; Heidelberger, S.; Zloh, M.; et al. Purification, characterisation and identification of acidocin LCHV, an antimicrobial peptide produced by Lactobacillus acidophilus n.v. Er 317/402 strain Narine. Int. J. Antimicrob. Agents, 2010, 35, 255-260.
29. Salvucci, E.; Saavedra, L.; Hebert, E.M.; Haro, C.; et al. Enterocin CRL35 inhibits Listeria monocytogenes in a murine model. Foodborne Pathog. Dis., 2012, 9, 68-74.